Antidiabetic drugs, glycemic control and risk of benign prostatic hyperplasia. Nygard LH, Talala K, Taari K, Tammela TLJ, et al. Prostate 2022 Nov 3. doi: 10.1002/pros.24456.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nygard LH, Talala K, Taari K, Tammela TLJ, et al. Antidiabetic drugs, glycemic control and risk of benign prostatic hyperplasia. Prostate 2022 Nov 3. doi: 10.1002/pros.24456.
PMID: 36325820